Table 2.
Parameter | Baseline |
Magnitude effect |
||
---|---|---|---|---|
Mdiff | dBF | Mdiff | dBF | |
Log(k) | 2.66 | 116.34 | −0.10 | 0.42 |
Temp | 0.03 | 1.36 | −0.01 | 0.89 |
aFor each parameter, we report mean posterior group differences (Mdiff) and BFs (dBF) testing for directional effects on both the baseline parameter in the 100€ condition (left columns) and on the magnitude effect on each parameter (right columns). BFs < 0.33 reflect evidence for placebo < haloperidol, whereas BFs >3 reflect evidence for placebo > haloperidol. For details, see Statistical analyses.